I am a
Home I AM A Search Login

Papers of the Week

Papers: 26 Aug 2023 - 1 Sep 2023


Genetics, Human Studies, Neurobiology, Pharmacology/Drug Development

Inflammation/Inflammatory, Musculoskeletal Pain, Psychological/Comorbidities

2023 Aug 25

Annu Rev Genomics Hum Genet



Sickle Cell Disease: From Genetics to Curative Approaches.


Hardouin G, Magrin E, Corsia A, Cavazzana M, Miccio A, Semeraro M


Sickle cell disease (SCD) is a monogenic blood disease caused by a point mutation in the gene coding for β-globin. The abnormal hemoglobin [sickle hemoglobin (HbS)] polymerizes under low-oxygen conditions and causes red blood cells to sickle. The clinical presentation varies from very severe (with acute pain, chronic pain, and early mortality) to normal (few complications and a normal life span). The variability of SCD might be due (in part) to various genetic modulators. First, we review the main genetic factors, polymorphisms, and modifier genes that influence the expression of globin or otherwise modulate the severity of SCD. Considering SCD as a complex, multifactorial disorder is important for the development of appropriate pharmacological and genetic treatments. Second, we review the characteristics, advantages, and disadvantages of the latest advances in gene therapy for SCD, from lentiviral-vector-based approaches to gene-editing strategies.